Elevated Capital Advisors’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$352K Sell
7,543
-7,637
-50% -$353K 0.1% 177
2026
Q1
$744K Sell
15,180
-4,320
-22% -$201K 0.19% 130
2025
Q4
$850K Buy
19,500
+607
+3% +$27.7K 0.2% 132
2025
Q3
$850K Sell
18,893
-3,053
-14% -$134K 0.21% 128
2025
Q2
$1.01M Hold
21,946
0.28% 95
2025
Q1
$1.01M Buy
21,946
+191
+0.9% +$7.98K 0.28% 95
2024
Q4
$819K Sell
21,755
-134
-0.6% -$5.2K 0.22% 134
2024
Q3
$888K Sell
21,889
-445
-2% -$16.7K 0.24% 128
2024
Q2
$773K Buy
+22,334
New +$824K 0.22% 126

Other funds holding EXC

Elevated Capital Advisors's EXC Position: Q2 2026 in Review

Elevated Capital Advisors reduced its Exelon (EXC) stake by 50% in Q2 2026, selling an estimated $353K and leaving 7,543 shares worth $352K. The position accounts for 0.1% of the portfolio, ranked #177.

Elevated Capital Advisors first reported a position in EXC in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.01M in Q2 2025. 1,286 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • Elevated Capital Advisors held 7,543 shares of Exelon worth $352K as of Q2 2026.
  • Elevated Capital Advisors sold 7,637 Exelon shares in Q2 2026, an estimated $353K.
  • Exelon made up 0.1% of Elevated Capital Advisors's portfolio in Q2 2026, its #177 holding.
  • Elevated Capital Advisors first reported a position in Exelon in Q2 2024 and has held it in 9 quarters since.
  • Elevated Capital Advisors's Exelon position peaked at $1.01M in Q2 2025.
  • 1,286 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on Elevated Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.